Abstract
Imaging is crucial to the diagnosis of pulmonary hydatid disease, as it is often the first modality that raises suspicion of the disease. Middle lobe syndrome (MLS) as a presentation of this disease is a distinct rarity. A 45-year-old woman, a never-smoker, presented with cough and streaky haemoptysis. Imaging demonstrated a trapezoidal opacity with its base towards the hilum and contiguous with the right cardiac border. The reformatted sagittal view confirmed the diagnosis of MLS. Fibreoptic bronchoscopy (FOB) revealed an avascular white membranous structure wholly occluding the medial segment of the middle lobe. This was completely removed through gentle suction. Bronchial aspirate revealed hooklets of hydatid and echinococcal serology was positive. Subsequently, three cycles of albendazole were administered with remarkable clinical and radiological improvement. To the best of our knowledge, this is the first detailed description of MLS caused by pulmonary hydatidosis that was completely removed through FOB.
Background
Hydatidosis, a zoonotic disorder, is caused by the tapeworm of the Echinococcus species and is not uncommon in India.1 Humans, the accidental host, are infested when they come in direct contact with primary hosts, such as dogs and cats, as well as sheep and goats. The parasite predominantly affects the liver and lung.2 Pulmonary hydatid disease often remains asymptomatic for a long time. Radiological imaging and serological tests are crucial to the diagnosis.3 Fibreoptic bronchoscopy (FOB) is usually not needed for the diagnosis of pulmonary hydatid disease. This may be required when the presentation is unusual and diagnosis is not suspected.
Middle lobe syndrome (MLS) as a presentation of pulmonary hydatid disease is a distinct rarity with only six patients being documented in four reports4–7 since 1977. In none of the documented patients was pulmonary hydatid disease suspected. The term ‘middle lobe syndrome’ was coined by Graham et al8 in 1948 to describe chronic or recurrent collapse of the right middle lobe. The first description of recurrent collapse of right middle lobe due to enlarged tuberculous lymph nodes was documented by Brock et al9 in 1937. MLS due to tuberculous aetiology is still widely known as ‘Brock's syndrome’.9 This distinct clinical entity, though uncommon, continues to tantalise clinicians, as it is caused by a wide spectrum of respiratory disorders, and is yet to be fully understood.
The paucity of literature on the subject prompted this report of a middle-aged woman with hydatid lung disease who presented as a MLS. The diagnosis was suspected during FOB and the membranous structure blocking the bronchus was successfully removed by gentle suction.
Case presentation
A 45-year-old HIV-negative woman, a farm worker, was referred to our Institute for evaluation of cough and streaky haemoptysis for the last 1 year. She had never smoked but had a significant history of exposure to biomass fuel smoke for more than 30 years. Based on her symptomatic and radiological profile, though sputum stains and cultures were repeatedly negative for Mycobacterium tuberculosis, she had received antituberculous therapy for 9 months without relief. The persistence of haemoptysis along with the right lower zone opacity on the chest radiograph for 9 months prompted a referral to our institute.
Examination revealed a middle-aged woman in no acute respiratory distress. There was no evidence of pallor, no cyanosis, no clubbing and no lymphadenopathy. She was afebrile with a respiratory count of 18 breaths/min. Diaphragmatic excursion was comparable on both sides. Vesicular breath sounds were audible but the intensity was reduced on the right lower hemithorax.
Investigations
Oxygen saturation at room air was 98%. The patient's haemoglobin was 11.6 g% and total leucocyte count was 8300 cells/mm3 with neutrophilic predominance. ECG, urine analyses, renal and hepatic functions were within normal limits. Sputum stains and culture for M. tuberculosis and other aerobic organisms were negative. Fungal culture did not reveal any growth. The chest radiograph (figure 1) showed an ill-defined opacity in the right mid and lower zones abutting the right cardiac border with loss of cardiac silhouette suggestive of right MLS. High-resolution contrast-enhanced CT of the thorax (figure 2A, B) revealed a trapezoidal opacity with its base towards the hilum and contiguous with the right cardiac border, while the reformatted sagittal view too showed a wedge-shaped density extending from the hilum anteriorly and inferiorly towards the chest wall, confirming the presence of MLS (figure 3A, B).
Figure 1.

Chest X-ray showing ill-defined opacity in the right mid and lower zones abutting the right cardiac border with loss of cardiac silhouette suggestive of right middle lobe syndrome.
Figure 2.
(A and B) High-resolution CT of the thorax (mediastinal and lung window) showing a trapezoidal opacity with its base towards the hilum and contiguous with the right cardiac border.
Figure 3.
(A and B) High-resolution CT of the thorax reformatted sagittal view (mediastinal and lung window) showing a wedge-shaped density extending from the hilum anteriorly and inferiorly towards the chest wall, confirming the presence of middle lobe syndrome.
In view of the MLS, the patient's consent was taken for a FOB, which visualised an avascular white membranous structure completely occluding the orifice of the medial segment of right middle lobe (figure 4A, B). The white membranous structure was slowly and completely removed through FOB by repeated but gentle suction. After suction, the medial segment of middle lobe bronchus opened completely (figure 5). The removal of the membranes was uneventful with no evidence of anaphylaxis. Stains and cultures of bronchial aspirate were negative for mycobacterial and other organisms. Bronchial aspirate revealed hooklets of hydatid. Serum sample sent for echinococcal serology was also positive. Ultrasonography of the abdomen did not show any hepatic involvement. On subsequent interrogation, the patient admitted to having dogs as pets, as well as keeping goats at the farm.
Figure 4.
(A) Fibreoptic bronchoscopic (FOB) image showing an avascular white membranous structure completely occluding the orifice of the medial segment of right middle lobe. (B) FOB image showing the white membranous structure being slowly and completely removed through FOB by repeated but gentle suction.
Figure 5.

Fibreoptic bronchoscopic image (postsuction) showing the medial segment of middle lobe bronchus opened completely.
Diagnosis
A diagnosis of complicated endobronchial hydatid cyst presenting as a MLS was made.
Treatment
In view of the complete removal of the membranes and full opening of the bronchus after FOB, conservative management was considered and the patient was initiated on oral albendazole. Three cycles of albendazole 200 mg three times a day were given (cycle of 6 weeks: drug for 4 weeks with an interval of 2 weeks) with no untoward reaction.
Outcome and follow-up
Remarkable clinical and radiological improvement was observed and after completion of the three treatment cycles, the patient was completely asymptomatic.
Discussion
Hydatid disease occurs worldwide but is endemic in certain regions such as the Mediterranean, the Middle East, Australia and South America.10 Pulmonary hydatid disease is often encountered by pulmonologists and imaging plays a crucial part in the diagnosis. Radiologically, pulmonary hydatid disease has a protean presentation and can be thought of as a ‘picturesque’ clinical entity. Although on imaging pulmonary hydatid disease has myriad appearances, MLS as a specific manifestation of this zoonotic ailment has rarely been documented. A search of the literature on the subject using the PubMed, IndMed and other databases revealed, to date, four reports documenting six patients of pulmonary hydatid disease who presented as MLS (table 1).4–7 However, there is only one detailed case report available in the English language literature.6 Furthermore, a scan of six major review articles on MLS11–16 since 1982, including a recent review in the paediatric population,16 found no mention of hydatidosis as a cause of MLS.
Table 1.
Summary of the six documented patients with pulmonary hydatid disease presenting as MLS along with the patient being reported
| Serial number | Author, year of publication, country | Number of patients/age/sex | Symptoms | Radiology | Bronchoscopy findings | Hydatid serology | Histopathology | Management |
|---|---|---|---|---|---|---|---|---|
| 1 | Jelić, et al,4 1977, Croatia (only abstract in English | 1/NA/NA | NA | NA | NA | NA | NA | NA |
| 2 | Modarres, et al,5 2008, Iran (only abstract in English) | 1/71/M | Chronic cough, haemoptysis | CT chest: RML—consolidation | RML and RLL: inflammation, erythaema | NA | Hydatid cyst | Surgical removal |
| 3 | Sokucu et al,6 2011, Turkey | 1/50/F | Haemoptysis: 3 months | CXR: right paracardiac infiltrate CT chest: RML—consolidation with air bronchogram, acinar nodules, ground glass opacities |
Medial segment of RML: whitish membranous material | Indirect Haemagglutination positive |
Homogeneous, eosinophilic, lamellar cuticle membrane with chronic inflammatory cells. | Right middle lobectomy |
| 4 | Pejhan et al,7 2015, Iran | 3/NA/NA | NA | NA | NA | NA | NA | Surgical removal |
| 5 | Present Study | 1/45/F | Cough, haemoptysis | CXR: right mid and lower zones opacity abutting the right cardiac border, loss of cardiac silhouette Chest CT: MLS |
Medial segment of RML: whitish membrane | Positive: E. granulosus | Bronchial aspirate: Hooklets | Completely extracted by FOB: albendazole—3 cycles |
CXR, chest X-ray; E. granulosus, Echinococcus granulosus; FOB, fibreoptic bronchoscopy; MLS, middle lobe syndrome; NA, not available; RML, right middle lobe.
MLS is classified as being either of an obstructive or non-obstructive type. Obstructive MLS is characterised by intraluminal or extraluminal compression of the middle lobe bronchus while in the non-obstructive type, a patent middle lobe bronchus is visualised on bronchoscopy.15 The obstructive form of MLS is usually caused by endobronchial tumours, lymphadenopathies, a foreign body or granulomatous infection, while benign inflammatory causes are implicated in 62% of the non-obstructive variant.12 Primary tumours as a cause of MLS are seen in 24% of patients while tuberculosis is responsible for 8–10%.12 Other less common causes of MLS include allergic bronchopulmonary aspergillosis,17–19 bronchial anthracofibrosis20 and even endobronchial tuberculosis.21 The middle lobe has a greater propensity to collapse as the bronchus is narrow at its origin, has a long length and an angular take-off from the bronchus intermedius. To add to this, the collateral ventilation is poor due to its anatomical isolation from the upper and lower lobes.15
Imaging is the initial diagnostic modality for MLS and the condition presents as a homogeneous opacity abutting the right cardiac border with a loss of cardiac silhouette. The lateral view shows a characteristic wedge-shaped opacity extending anterior and inferior to the hilum. On CT, MLS appears as a trapezoidal opacity with its base towards the hilum and contiguous with the right cardiac border,15 as was seen in our patient.
The typical radiological appearance of an uncomplicated hydatid cyst is a well-defined, round to oval homogeneous opacity surrounded by normal parenchyma. The various classical signs include ‘air-crescent sign or Monod sign’ suggestive of impending rupture while ‘serpent sign’, ‘water-lily sign or Camelotte sign’, ‘onion peel appearance or Cumbo sign’ are seen in partially ruptured or ruptured pulmonary hydatid cysts. However, in patients with ruptured or secondary infection of these cysts, atypical radiological features can lead to diagnostic delay.3 CT scans also help in localising and confirming the cystic nature of the lesion as well as in determining the wall thickness.22
Serology has emerged as an important diagnostic modality of pulmonary hydatidosis with sensitivity of serum antibody detection using indirect haemagglutination, ELISA, or latex agglutination, varying between 85% and 98% for hepatic cysts, 50% and 60% for lung cysts and 90% and 100% in cases of multiple organ cysts.23 Our patient also had a positive echinococcal serology and the diagnosis was confirmed on detection of hooklets in the bronchial aspirate.
Bronchoscopy in pulmonary hydatid disease is usually performed when the radiological appearance is atypical and the diagnosis is not suspected,24 as in our patient. This generally occurs in complicated pulmonary hydatidosis, which may mimic tuberculosis, malignancy, empyema or lung abscess.25 Opinion regarding the role of FOB for the diagnosis of pulmonary hydatid disease is divided, as the risk of rupturing the uncomplicated cyst and the subsequent possible anaphylaxis remains.24 However, recent literature suggests that FOB may be useful in the diagnosis as well as in the treatment, as was seen in our patient.
We also reviewed the existing literature regarding the use of FOB as a therapeutic modality in pulmonary hydatidosis and found four reports documenting five patients (table 2).26–29 Of the five patients, two were females28 29 and one was male,26 while demographic details were not available for the remaining two.27 As in our patient, the diagnosis of pulmonary hydatid disease was not considered in any of the five patients prior to FOB. In all the five patients, FOB visualised a complicated pulmonary hydatid cyst, which was completely and successfully removed by gentle suction through FOB. Anaphylaxis was not documented in any of the four reports.
Table 2.
Summary of the five documented patients with pulmonary hydatid disease with complete extraction through FOB
| Serial number | Author, year of publication, country | Number of patients/age/sex | Symptoms | Radiology | Bronchoscopy findings | Hydatid serology | Histopathology | Management |
|---|---|---|---|---|---|---|---|---|
| 1 | Bousnina et al,26 2005, France (only abstract in English) | 1/74/M | Cough, haemoptysis | CXR: upper third of left lung—heterogeneous opacity | Left superior bronchus: hydatid membrane | NA | NA | Completely aspirated by FOB |
| 2 | Racil et al,27 2009, France (only abstract in English) | 2/NA/NA | NA | NA | NA | NA | NA | Complete bronchoscopic extraction: two patients |
| 3 | Alavia et al,28 2010, Iran | 1/26/F | Cough, yellowish brown expectoration, exertional dyspnoea, night sweats, fever: 5 months | CXR: alveolar opacity—lower zone of right lung CT chest: RLL—alveolar involvement, mild pleural effusion and thick wall cystic lesion: posterior surface of liver |
Posterior basal segment of RLL: whitish-yellow bright gelatinous membrane | NA | Membranous lesion with laminated layer and germinal covering | Therapeutic FOB: forceps fragmentation, complete suction albendazole |
| 4 | Sharif et al,29 2011, Iran | 1/22/F | Cough, haemoptysis: 2 months | CXR: left lower zone—homogeneous opacity CT chest: superior segment of LLL—consolidation |
Superior segment of LLL: whitish endobronchial mass | Positive | Two layers of cyst wall with histopathological confirmation | Completely aspirated by FOB |
CXR, chest X-ray; FOB, fibreoptic bronchoscopy; LLL, left lower lobe; NA, not available; RLL, right lower lobe.
Chemotherapy with albendazole is indicated in non-operable cases, and also in preoperative and postoperative patients, to lower the risk of recurrences caused by spillage of cyst contents. Chemotherapy, in our patient, was also administered to decrease the risk of recurrence.23
Hydatid as a cause of MLS is a diagnostic rarity and in certain situations can be completely removed through FOB, obviating the need for surgery.
Learning points.
Hydatid disease is a major public health issue throughout the world, especially in endemic countries.
The myriad radiological appearances of pulmonary hydatid disease makes it a ‘picturesque’ clinical entity.
Pulmonary hydatid disease presenting as middle lobe syndrome is a distinct diagnostic rarity.
Middle lobe syndrome continues to intrigue physicians with its characteristic radiological picture caused by a wide spectrum of pulmonary diseases.
The role of fibreoptic bronchoscopy in diagnosis and management of pulmonary hydatid disease is yet to be defined.
Footnotes
Contributors: SK, VP and AS collected the clinical data and reviewed the literature. SK, VP and AS drafted the manuscript and were responsible for the clinical work up of the patient. AS is the guarantor. All the authors have read and approved the final manuscript.
Competing interests: None declared.
Patient consent: Obtained.
Provenance and peer review: Not commissioned; externally peer reviewed.
References
- 1.Khader Faheem N, Nusrath N, Syama Sundara Rao B et al. The scenario of hydatid cyst disease in epidemic areas of Andhra Pradesh—evaluation and analysis. Int J Res Dev Health 2013;1:120–8. [Google Scholar]
- 2.Gottstein B, Reichen J. Hydatid lung disease (echinococcosis/hydatidosis). Clin Chest Med 2002;23:397–408. 10.1016/S0272-5231(02)00007-2 [DOI] [PubMed] [Google Scholar]
- 3.Morar R, Feldman C. Pulmonary echinococcosis. Eur Respir J 2003;21:1069–77. 10.1183/09031936.03.00108403 [DOI] [PubMed] [Google Scholar]
- 4.Jelić R, Barić D, Padelin J et al. [Some interesting cases of pulmonary echinococcosis] [Article in Croatian]. Acta Chir Iugosl 1977;24:235–42. [PubMed] [Google Scholar]
- 5.Modarres SR, Nikbakhsh N, Pooya M. A case report of middle lobe syndrome due to hydatid cyst. J Babol Univ Med Sci 2008;10:81–4. [Google Scholar]
- 6.Sokucu SN, Dalar L, Karasulu L et al. A mismanaged case of hydatid disease of lung. J Pak Med Assoc 2011;61:1128–9. [PubMed] [Google Scholar]
- 7.Pejhan S, Salehi F, Niusha S et al. Ten years' experience in surgical treatment of right middle lobe syndrome. Ann Thorac Cardiovasc Surg 2015;21:354–8. 10.5761/atcs.oa.14-00273 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Graham EA, Burford TH, Mayer JH. Middle lobe syndrome. Postgrad Med 1948;4:29–34. [DOI] [PubMed] [Google Scholar]
- 9.Brock RC, Cann RJ, Dickinson JR. Tuberculous mediastinal lymphadenitis in childhood: secondary effects on the lungs. Guy's Hosp Rep 1937;87:295. [Google Scholar]
- 10.Kuzucu A, Soysal O, Ozgel M et al. Complicated hydatid cysts of the lung: clinical and therapeutic issues. Ann Thorac Surg 2004;77:1200–4. 10.1016/j.athoracsur.2003.09.046 [DOI] [PubMed] [Google Scholar]
- 11.Saha SP, Mayo P, Long GA et al. Middle lobe syndrome: diagnosis and management. Ann Thorac Surg 1982;33:28–31. 10.1016/S0003-4975(10)63193-1 [DOI] [PubMed] [Google Scholar]
- 12.Wagner RB, Johnston MR. Middle lobe syndrome. Ann Thorac Surg 1983;35:679–86. 10.1016/S0003-4975(10)61085-5 [DOI] [PubMed] [Google Scholar]
- 13.Gudmundsson G, Gross TJ. Middle lobe syndrome. Am Fam Physician 1996;53:2547–50. [PubMed] [Google Scholar]
- 14.Robinson DA, Lee PC. Middle lobe syndrome: case report and review of literature. Clin Pul Med 2007;14:244–8. 10.1097/CPM.0b013e3180d09c8f [DOI] [Google Scholar]
- 15.Gudbjartsson T, Gudmundsson G. Middle lobe syndrome: a review of clinicopathological features, diagnosis and treatment. Respiration 2012;84:80–6. 10.1159/000336238 [DOI] [PubMed] [Google Scholar]
- 16.Romagnoli V, Priftis KN, de Benedictis FM. Middle lobe syndrome in children today. Paediatr Respir Rev 2014;15:188–93. 10.1016/j.prrv.2014.01.002 [DOI] [PubMed] [Google Scholar]
- 17.Shah A, Bhagat R, Panchal N et al. Allergic bronchopulmonary aspergillosis with middle lobe syndrome and allergic Aspergillus sinusitis. Eur Respir J 1993;6:917–18. [PubMed] [Google Scholar]
- 18.Shah A, Behera S, Panjabi C. Middle lobe syndrome: a rare presentation of allergic bronchopulmonary aspergillosis. Eur Ann Allergy Clin Immunol 2014;46:147–51. [PubMed] [Google Scholar]
- 19.Shah A, Gera K, Panjabi C. Childhood allergic bronchopulmonary aspergillosis presenting as a middle lobe syndrome. Asia Pac Allergy 2016;6:67–9. 10.5415/apallergy.2016.6.1.67 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Kala J, Sahay S, Shah A. Bronchial anthracofibrosis and tuberculosis presenting as a middle lobe syndrome. Prim Care Respir J 2008;17:51–5. 10.3132/pcrj.2008.00003 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Garg T, Gera K, Shah A. Middle lobe syndrome: an extraordinary presentation of endobronchial tuberculosis. Pneumonol Alergol Pol 2015;83:387–91. 10.5603/PiAP.2015.0062 [DOI] [PubMed] [Google Scholar]
- 22.Koul PA, Koul AN, Wahid A et al. CT in pulmonary hydatid disease: unusual appearances. Chest 2000;118:1645–7. 10.1378/chest.118.6.1645 [DOI] [PubMed] [Google Scholar]
- 23.Brunetti E, Kern P, Vuitton DA, Writing Panel for the WHO-IWGE. Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans. Acta Trop 2010;114:1–16. 10.1016/j.actatropica.2009.11.001 [DOI] [PubMed] [Google Scholar]
- 24.Deshmukh VS, Athavale AU, Bhaskar MA. Bronchoscopy in pulmonary hydatidosis: retrospective analysis. J Bronchology Interv Pulmonol 2009;16:172–5. 10.1097/LBR.0b013e3181afcccb [DOI] [PubMed] [Google Scholar]
- 25.Yilmaz A, Tuncer LY, Damadoglu E et al. Pulmonary hydatid disease diagnosed by bronchoscopy: a report of three cases. Respirology 2009;14:141–3. 10.1111/j.1440-1843.2008.01390.x [DOI] [PubMed] [Google Scholar]
- 26.Bousnina S, Zendah I, Marniche K et al. [Complete extraction of a hydatid membrane by bronchial fibroscopy] [Article in French]. Rev Pneumol Clin 2005;61:270–4. 10.1016/S0761-8417(05)84825-4 [DOI] [PubMed] [Google Scholar]
- 27.Racil H, Ben Amar J, El Filali Moulay R et al. [Complicated hydatid cysts of the lung] [Article in French]. Rev Mal Respir 2009;26:727–34. 10.1016/S0761-8425(09)72423-4 [DOI] [PubMed] [Google Scholar]
- 28.Alavia A, Aghajanzadeh M, Hejig M. Bronchoscopic extraction of a hydatid membrane in a 26-year old woman with recurrent pneumonia; case report. Iranian Red Crescent Med J (IRCMJ) 2010;12:68–70. [Google Scholar]
- 29.Sharif A, Ansarin K, Rashidi F et al. Bronchoscopic diagnosis and removal of a ruptured hydatid cyst. J Bronchology Interv Pulmonol 2011;18:362–4. 10.1097/LBR.0b013e31823504ac [DOI] [PubMed] [Google Scholar]



